Molecular insights into blood groups and implications for blood transfusion

Current Opinion in Hematology

Volumn 5, Issue 2, 1998, Pages 93-102

  Reid, Marion E ^a   Yazdanbakhsh, Karina ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; RHESUS D ANTIGEN;

BLOOD GROUP; BLOOD GROUP A; BLOOD GROUP B; BLOOD TRANSFUSION; COOMBS TEST; ERYTHROCYTE; FORENSIC SCIENCE; GENOTYPE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKOCYTE; MOLECULAR GENETICS; NEWBORN HEMOLYTIC DISEASE; PATERNITY TEST; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STEM CELL; TISSUE TYPING;

EID: 0031948731     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199803000-00003     Document Type: Review

References (130)

1. Daniels GL, Anstee DJ, Cartron J-P, Dahr W, Issitt PD, Jorgensen J, Kornstad L, Lewis M, Levene C, Lomas-Francis C, et al.: Blood group terminology 1995. From the ISBT Working Party on Terminology for Red Cell Surface Antigens. Vox Sang 1995, 69:265-279.
2. Giblett ER: A critique of the theoretical hazard of inter vs. intra-racial transfusion. Transfusion 1961, 1:233-238.
3. Giblett ER: Blood group alloantibodies: an assessment of some laboratory practices. Transfusion 1977, 4:299-308.
4. Hoettge GA, Domen RE, Rybicki LA, Schaffer PA: Multiple red cell transfusions and alloimmunization: experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995, 119:42-45.
5. Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R: Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997, 89:272-275.
6. Larsen RD, Ernst LK, Nair RP, Lowe JB: Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci U S A 1990, 87:6674-6678.
7. Wang BJ, Koda Y, Soejima M, Kimura H: Two missense mutations of H type α(1,2)fucosyltransferase gene (FUT1) responsible for para-Bombay phenotype. Vox Sang 1997, 72:31-35.
8. Yu L-C, Yang Y-H, Broadberry RE, Chen Y-H, Lin M: Heterogeneity of the human H blood group α (1,2) fucosyltransferase gene among para-Bombay individuals. Vox Sang 1997, 72:36-40.
9. Rouquier S, Lowe JB, Kelly RJ, Fertitta AL, Lennon GG, Giorgi D: Molecular cloning of a human genomic region containing the H blood group α(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. J Biol Chem 1995, 270:4632-4639.
10. Kelly RJ, Ernst LK, Larsen RD, Bryant JG, Robinson JS, Lowe JB: Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay Individuals. Proc Natl Acad Sci U S A 1994, 91:5843-5847.
11. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB: Sequence and expression of a candidate for the human secretor blood group α(1,2)fucosyltransferase gene (FUT2). J Biol Chem 1995, 270:4640-4649.
12. Chandrasekaran EV, Jain RK, Larsen RD, Wlasichuk K, Matta KL: Characterization of the specificities of human blood group H gene-specified α1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: evidence for an inverse relationship between α1,2-L-fucosylation of Gal and α1,6-L-fucosylation of asparagine-linked GlcNAc. Biochemistry 1996, 35:8914-8924.
13. Prieto PA, Larsen RD, Cho M, Rivera HN, Shilatifard A, Lowe JB, Cummings RD, Smith DF: Expression of human H-type α1,2-fucosyl-transferase encoding for blood group H(O) antigen in Chinese hamster ovary cells-evidence for preferential fucosylation and truncation of polylactosamine sequences. J Biol Chem 1997, 272:2089-2097.
14. Wagner FF, Flegel WA: Polymorphism of the h allele and the population frequency of sporadic nonfunctional alleles. Transfusion 1997, 37:284-290.
15. Olsson ML, Guerreiro JF, Zago MA, Chester MA: Molecular analysis of the O alleles at the blood group ABO locus in populations of different ethnic origin reveals novel crossing-over events and point mutations. Biochem Biophys Res Commun 1997, 234:779-782.
16. Yamamoto F-I, Clausen H, White T, Marken J, Hakomori S: Molecular genetic basis of the histo-blood group ABO system. Nature 1990, 345:229-235.
17. Gassner C, Schmarda A, Nussbaumer W, Schönitzer D: ABO glycosyl-transferase genotyping by polymerase chain reaction using sequence-specific primers. Blood 1996, 88:1852-1856.
18. 2. Vox Sang 1994, 67:210-215.
19. Ogasawara K, Yabe R, Uchikawa M, Saitou N, Bannai M, Nakata K, Takenaka M, Fujisawa K, Ishikawa Y, Juji T, et al.: Molecular genetic analysis of variant phenotypes of the ABO blood group system. Blood 1996, 88:2732-2737.
20. Ogasawara K, Bannai M, Saitou N, Yabe R, Nakata K, Takenaka M, Fujisawa K, Uchikawa M, Ishikawa Y, Juji T, et al.: Extensive polymorphism of ABO blood group gene: three major lineages of the alleles for the common ABO phenotypes. Hum Genet 1996, 97:777-783.
21. 1 gene at the blood group ABO locus. Vox Sang 1996, 70:26-30.
22. ol nucleotide insertion. Vox Sang 1996, 71:113-117.
23. 2 discriminating nucleotide substitution at the ABO locus. Vox Sang 1995, 69:242-247.
24. Stroncek DF, Konz R, Clay ME, Houchins JP, McCullough J: Determination of ABO glycosyltransferase genotypes by use of polymerase chain reaction and restriction enzymes. Transfusion 1995, 35:231-240.
25. Yamamoto F: Molecular genetics of the ABO histo-blood group system. Vox Sang 1995, 69:1-7.
26. Watanabe G, Umetsu K, Yuasa I, Suzuki T: Amplified product length polymorphism (APLP): a novel strategy for genotyplng the ABO blood group. Hum Genet 1997, 99:34-37.
27. Suzuki K, Iwata M, Tsuji H, Takagi T, Tamura A, Ishimoto G, Ito S, Matsui K, Miyazaki T: A de novo recombination in the ABO blood group gene and evidence for the occurrence of recombination products. Hum Genet 1997, 99:454-461.
28. Carritt B, Kemp TJ, Poulter M: Evolution of the human RH (rhesus) blood group genes: a 50 year old prediction (partially) fulfilled. Hum Mol Genet 1997, 6:843-850.
29. Huang C-H: Molecular insights into the Rh protein family and associated antigens. Curr Opin Hematol 1997, 4:94-103.
30. Cartron J-P: Defining the Rh blood group antigens: biochemistry and molecular genetics. Blood Rev 1994, 8:199-212.
31. Tippett P, Lomas-Francis C, Wallace M: The Rh antigen D: partial D antigens and associated low incidence antigens. Vox Sang 1996, 70:123-131.
32. u), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene. Blood 1997, 89:2568-2577.
33. N phenotypes. Blood 1996, 87:4853-4861.
34. Beckers EAM, Faas BH, Ligthart P, Overbeeke MA, von dem Borne AEGKr, van der Schoot CE, Van Rhenen DJ: Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene. Transfusion 1997, 37:616-623.
35. Apoil PA, Reid ME, Halverson G, Mouro I, Colin Y, Roubinet F, Cartron J-P, Blancher A: A human monoclonal anti-D antibody which detects a nonconformation-dependent epitope on the RhD protein by immunoblotting. Br J Hematol 1997, 98:365-374.
36. IIIa erythrocytes: RhD protein is associated with multiple dispersed amino acid variations. Am J Hematol 1997, 55:139-145.
37. Flegel WA, Müller TH, Schunter F, Gassner C, Schönitzer D, Wagner FF: D category VI Type III: A D-Ce(3-6)-D hybrid protein with normal RHD antigen density on red cells [abstract]. Transfusion 1997, 37(Suppl):101S.
38. Rouillac C, Colin Y, Hughes-Jones NC, Beolet M, D'Ambrosio A-M, Cartron J-P, Le Van Kim C: Transcript analysis of D category phenotypes predicts hybrid Rh D-CE-D proteins associated with alteration of D epitopes. Blood 1995, 85:2937-2944.
39. VIccEe phenotypes. Blood 1997, 89:1779-1786.
40. VI category erythrocytes: correlation of the phenotype with a novel hybrid RhD-CE-D gene but not an internally deleted RhD gene. Blood 1997, 89:1834-1835.
41. VI phenotype. Am J Hum Genet 1997, 60:808-817.
42. Blunt T, Daniels G, Carritt B: Serotype switching in a partially deleted RHD gene. Vox Sang 1994, 67:397-401.
43. W-red blood cells: phenotypic homozygosity versus genotypic heterozygosity. Blood 1996, 88:2326-2333.
44. Chérif-Zahar B, Raynal V, Gane P, Mattei MG, Bailly P, Gibbs B, Colin Y, Cartron JP: Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency. Nat Genet 1996, 12:168-173.
45. Okuda H, Kawano M, Iwamoto S, Tanaka M, Seno T, Okubo Y, Kajii E: The RHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest 1997, 100:373-379.
46. Rose NC, Hurwitz C, Silberstein L, Andovalu R, Stoerker J: Prenatal analysis of rhesus CeDEe blood groups by heteroduplex generator. Am J Obstet Gynecol 1997, 176:1084-1089.
47. Aubin JT, Kim CL, Mouro I, Colin Y, Bignozzi C, Brossard Y, Cartron JP: Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification. Br J Haematol 1997, 98:356-364.
48. Steers F, Wallace M, Johnson P, Carritt B, Daniels G: Denaturing gradient gel electrophoresis: a novel method for determining Rh phenotype from genomic DNA. Br J Haematol 1996, 94:417-421.
49. Gassner C, Schmarda A, Kilga-Nogler S, Jenny-Feldkircher B, Rainer E, Müller TH, Wagner FF, Flegel WA, Schönitzer D: RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion 1997, 37:1020-1026.
50. Van den Veyver IB, Moise KJ Jr.: Fetal RhD typing by polymerase chain reaction in pregnancies complicated by rhesus alloimmunization. Obstet Gynecol 1996, 88:1061-1067.
51. Daniels G, Green C, Smart E: Differences between RhD-negative Africans and RhD-negative Europeans. Lancet 1997, 350:862-863.
52. Faas BHW, Beckers EAM, Wildoer P, Ligthart PC, Overbeeke MAM, Zondervan HA, Von dem Borne AEGK, van der Schoot CE: Molecular background of VS and weak C expression in blacks. Transfusion 1997, 37:38-44.
53. Carbonnet F, Hattab C, Collec E, Le Van Kim C, Cartron JP, Bertrand O: Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides. Br J Haematol 1997, 96:857-863.
54. Redman CM, Lee S: The Kell blood group system. Transfus Clin Biol 1995, 4:242-249.
55. Oyen R, Halverson GR, Reid ME: Review: conditions causing weak expression of Kell system antigens. Immunohematology 1997, 13:75-79.
56. Lee S: Molecular basis of Kell blood group phenotypes. Vox Sang 1997, 73:1-11.
57. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM: Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynec 1994, 171:247-252.
58. Weiner CP, Widness JA: Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996, 174:547-551.
59. Parilla BV, Socol ML: Hydrops fetalis with Kell isoimmunization. Obstet Gynecol 1996, 88:730.
60. Manning M, Warwick R, Vaughan J, Roberts IAG: Inhibition of erythroid progenitor cell growth by anti-Kell: a mechanism for fetal anaemia in Kell-immunized pregnancies [abstract]. Br J Haematol 1996, 93(Suppl 1):13.
61. Leggat HM, Gibson JM, Barron SL, Reid MM: Anti-Kell in pregnancy. Br J Obstet Gynaecol 1991, 98:162-165.
62. Inglis G, Fraser RH, McTaggart S, Sheridan R, Forrest AH, Mitchell R: Monoclonal antibodies to high-incidence Kell epitopes: characterization and application in automated screening of donor samples. Transfus Med 1994, 4:209-212.
63. Lee SH, Bennett PR, Overton T, Warwick R, Wu X, Redman CM: Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2. Am J Obstet Gynecol 1996, 175:455-459.
64. Mifsud NA, Haddad AP, Sparrow RL, Condon JA: Use of the polymerase chain reaction sequence specific oligonucleotide technique for the detection of the K1/K2 polymorphism of the Kell blood group system. Blood 1997, 89:4662-4663.
65. Avent ND, Martin PG: Kell typing by allele-specific PCR (ASP). Br J Haematol 1996, 93:728-730.
66. Murphy MT, Fraser RH: Detection of Kell blood groups: molecular methods in the diagnostic laboratory. Blood Rev 1997, 11:8-15.
67. Spence WC, Maddalena A, Demers DB, Bick DP: Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies. J Reprod Med 1997, 42:353-357.
68. Chaudhuri A, Polyakova J, Zbrzezna V, Pogo O: The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 1995, 85:615-621.
69. b blood group polymorphism. Hum Genet 1995, 95:407-410.
70. b alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 1995, 85:622-626.
71. b antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995, 90:823-829.
72. Hadley TJ, Peiper SC: From malaria to chemokine receptor the emerging physiologic role of the duffy blood group antigen. Blood 1997, 89:3077-3091.
73. Tournamille C, Colin Y, Cartron J-P, Le Van Kim C: Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nature Genet 1995, 10:224-228.
74. Iwamoto S, Li J, Sugimoto N, Okuda H, Kajii E: Characterization of the Duffy gene promotor: evidence for tissue-specific abolishment of expression in Fy(a-b-) of black individuals. Biochem Biophys Res Commun 1996, 222:852-859.
75. Chaudhuri A, Nielsen S, Elkjaer ML, Zbrzezna V, Fang F, Pogo AO: Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 1997, 89:701-712.
76. b antigens [abstract]. Transfus Med 1994, 4(Suppl):45.
77. Reid ME: Molecular basis for blood groups and function of carrier proteins. In Molecular and Functional Aspects of Blood Group Antigens. Edited by Silberstein LE, Arlington, VA: American Association of Blood Banks; 1995:75-125.
78. Olivés B, Mattei M-G, Huet M, Neau P, Martial S, Cartron J-P, Bailly P: Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem 1995, 270:15607-15610.
79. Olivès B, Merriman M, Bailly P, Bain S, Barnett A, Todd J, Cartron J-P, Merriman T: The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptibility. Hum Mol Genet 1997, 6:1017-1020.
80. 854->Leu. J Biol Chem 1994, 269:16155-16158.
81. Bruce LJ, Ring SM, Anstee DJ, Reid ME, Wilkinson S, Tanner MJA: Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3: a site of Interaction between band 3 and glycophorin A under certain conditions. Blood 1995, 85:541-547.
82. 552→IIe substitution in erythroid band 3 gives rise to the Warrior blood group antigen. Transfusion 1997, 37:398-405.
83. a are located in the third ectoplasmic loop of erythroid band 3. Transfusion 1997, 37:607-615.
84. Jarolim P, Rubin HL, Reid M: Characterization of six low incidence blood group antigens carried by erythrocyte band 3 [abstract], Transfusion 1996, 36(suppl):49S.
85. Jarolim P, Murray JL, Rubin HL, Taylor WM, Prchal JT, Ballas SK, Snyder LM, Chrobak L, Melrose WD, Brabec V, et al.: Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood 1996, 88:4366-4374.
86. Corfield VA, Moolman JC, Martell R, Brink PA: Polymerase chain reaction-based detection of MN blood group-specific sequences in the human genome. Transfusion 1993, 33:119-124.
87. Huang C-H, Guizzo ML, McCreary J, Leigh EM, Blumenfeld OO: Typing of MNSs blood group specific sequences In the human genome and characterization of a restriction fragment tightly linked to S-s-alleles. Blood 1991, 77:381-386.
88. DuPont BR, Grant SG, Oto SH, Bigbee WL, Jensen RH, Langlois RG: Molecular characterization of glycophorin A transcripts in human erythroid cells using RT-PCR, allele-specific restriction, and sequencing. Vox Sang 1995, 68:121-129.
89. Murray JC, Buetow KH, Ferrell RE, Sieberg PD, Fukuda M: An RFLP for glycoprotein A (MN) Is In linkage disequilibrium with MN and Ss. Cytogenet Cell Genet 1988, 47:149-151.
90. Grant SG, Jensen RH: Use of hematopoietic cells and markers for the detection and quantitation of human in vivo somatic mutation. In Immunobiology of Transfusion Medicine. Edited by Garratty G. New York: Marcel Dekker; 1994:299-323.
91. Jensen RH, Langlois RG, Bigbee WL, Grant SG, Moore D, Pilinskaya M, Vorobtsova I, Pleshanov P: Elevated frequency of glycophorin A mutations in erythrocytes from Chernobyl accident victims. Radiat Res 1995, 141:129-135.
92. Schiwietz J, Lorenz R, Scheubeck M, Börner W, Hempel K: Improved determination of variant erythrocytes at the glycophorin A (GPA) locus and variant frequency in patients treated with radioiodine for thyroid cancer. Int J Radiat Biol 1996, 70:131-143.
93. Kyoizumi S, Akiyama M, Cologne JB, Tanabe K, Nakamura N, Awa AA, Hirai Y, Kusunoki Y, Umeki S: Somatic cell mutations at the glycophorin a locus in erythrocytes of atomic bomb survivors: Implications for radiation carcinogenesis. Radiat Res 1996, 146:43-52.
94. Jensen RH, Reynolds JC, Robbins J, Bigbee WL, Grant SG, Langlois RG, Pineda JD, Lee TS, Barker C: Glycophorin A as a biological dosimeter for radiation dose to the bone marrow from iodine-131. Radiat Res 1997, 147:747-752.
95. Bigbee WL, Jensen RH, Veidebaum T, Tekkel M, Rahu M, Stengrevics A, Auvinen A, Hakulinen T, Servomaa K, Rytömaa T, et al.: Biodosimetry of Chemobyl cleanup workers from Estonia and Latvia using the glycophorin a in vivo somatic cell mutation assay. Radiat Res 1997, 147:215-224.
96. b polymorphisms. Blood 1997, 89:4219-4225.
97. b blood group polymorphism. Blood 1997, 89:4608-4616.
98. Bartels CF, Zelinski T, Lockridge O: Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. Am J Hum Genet 1993, 52:928-936.
99. - phenotypes. Blood 1996, 87:2962-2967.
100. Smith BL, Preston GM, Spring FA, Anstee DJ, Agre P: Human red cell aquaporin CHIP. 1. Molecular characterization of ABH and Colton blood group antigens. J Clin Invest 1994, 94:1043-1049.
101. Telen MJ, Udani M, Washington MK, Levesque MC, Lloyd E, Rao N: A blood group related polymorphism of CD44 abolishes a hyaluronan binding consensus sequence without preventing hyaluronan binding. J Biol Chem 1996, 271:7147-7154.
102. Reid ME, Lomas-Francis C: The Blood Group Antigen FactsBook. San Diego: Academic Press; 1996.
103. a blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues. Eur J Immunol 1997, 27:891-897.
104. Reid ME, Spring FA: Molecular basis of glycophorin C variants and their associated blood group antigens. Transfus Med 1994, 4:139-149.
105. Rao N, Ferguson DJ, Lee SF, Telen MJ: Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 1991, 146:3502-3507.
106. Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP: The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera. J Exp Med 1991, 173:1159-1163.
107. Moulds JM, Rowe KE: Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion 1996, 36:517-520.
108. Rowe JA, Moulds JM, Newbold CI, Miller LH: P-falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997, 388:292-295.
109. Reed W, Lee T-H, Busch MP, Vichinsky EP: Sample suitability for the detection of minor leukocyte populations by polymerase chain reaction (PCR) [abstract]. Transfusion 1997, 37(Suppl):107S.
110. Cheung M-C, Goldberg JD, Kan YW: Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 1996, 14:264-268.
111. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, Wainscoat JS: Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
112. Lee T-H, Paglieroni T, Ohro H, Holland PV, Busch MP: Longterm multi-lineage chimerism of donor leukocytes in transfused trauma patients [abstract]. Blood 1996, 88(Suppl 1):265a.
113. Huang C-H, Reid ME, Xie SS, Blumenfeld OO: Human red blood cell Wright antigens: a genetic and evolutionary perspective on glycophorin A-band 3 interaction. Blood 1996, 87:3942-3947.
114. Saba NF, Sweeney JD, Penn LC, Lawton JC, Yankee RL, Huang CH, Schanfield MS: Anti-D in a D-positive renal transplant patient. Transfusion 1997, 37:321-324.
115. Schafer AJ, Mawkins JR: DNA variation and the future of human genetics. Nat Biotechnol 1998, 16:33-39.
116. X (Rh9) blood group specificities. Blood 1995, 86:1196-1201.
117. Faas BHW, Ligthart PC, Lomas-Francis C, Overbeeke MAM, Von dem Borne AEGK, van der Schoot CE: Involvement of Gly96 in the formation of the RH:26 epitope. Transfusion 1997, 37:1123-1130.
118. Lee S, Wu X, Reid ME, Zelinski T, Redman C: Molecular basis of the Kell (K1) phenotype. Blood 1995, 85:912-916.
119. Lee S, Wu X, Son S, Naime D, Reid M, Okudo Y, Sistonen P, Redman C: Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles. Transfusion 1996, 36:490-494.
120. Lee S, Wu X, Reid ME, Redman C: Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system. Transfusion 1995, 35:822-825.
121. Lee S, Naime D, Reid M, Redman C: The KEL24 and KEL14 alleles of the Kell blood group system. Transfusion 1997, 37:1035-1038.
122. Kim DA, Kim TY, Choi TY: Genotyping of Diego blood group system by use of polymerase chain reaction and Nae I restriction enzyme [abstract]. Transfusion 1997, 37(Suppl):33S.
123. 557→Met in human erythrocyte band 3 (AE1 ). Vox Sang 1996, 71:118-120.
124. Zelinski T, Rusnak A, McManus K, Coghlan G: A G→A mutation in the anion exchanger 1 gene (AE1) accounts for the Swann blood group polymorphism [abstract]. Transfusion 1997, 37(Suppl):89S.
125. Leos SH, Bigbee WL, Jensen RH, Grant SG: SfaNI polymorphism distinguishes the alleles of the glycophorin A locus that determine the MN blood group. Acta Haematol 1997, 98:51-53.
126. Huang C-H, Blumenfeld OO: MNSs blood groups and major glycophorins: molecular basis for allelic variation. In Molecular Basis of Major Human Blood Group Antigens. Edited by Cartron J-P, Rouger P. New York: Plenum Press; 1995:153-183.
127. b blood group polymorphism. Blood 1995, 86:1590-1594.
128. a antigen on glycophorin D but not on glycophorin C: further evidence that glycophorin D is a product of the GYPC gene. Blood 1993, 82:3198-3203.
129. a epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 1994, 84:3205-3211.
130. Lublin DM, Mallinson G, Poole J, Reid ME, Thompson ES, Ferdman BR, Telen MJ, Anstee DJ, Tanner MJ: Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994, 84:1276-1282.